It is not FDA-approved, and this page covers research evidence rather than human-use guidance
The injection is very easy to give yourself, and painless
I started off weighing 138lbs and I am now 132lbs towards the tail end of the month
Marketed as Victoza for type 2 diabetes (approved 2010) and Saxenda for chronic weight management (approved 2014), liraglutide paved the way for the current generation of GLP-1 weight loss medications, including its successor semaglutide
WADA statement on substance AOD-9604
This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.